Sort
15,440 grants matching “organoids”
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
$392,373Seth E Frietze · University Of Vermont & St Agric College · P01 · FY2021 · CA
Roles of Glial Autophagy in Breast Cancer Brain Metastasis
$392,322Chenran Wang · Ohio State University · R01 · FY2025 · CA
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
$392,306Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
$392,306Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Basal Progenitor Cells and Eosinophilic Esophagitis
$392,247Jianwen Que · Columbia University Health Sciences · R01 · FY2020 · DK
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$392,202Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Role of retinoic acid signaling in fovea development
$392,181Susana Isabel M M A Da Silva · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · EY
Cellular and molecular mechanisms of brain dysfunction in NF1
$392,178Nan Yang · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
Stromal metabolism promotes therapeutic resistance in pancreatic cancer
$392,124Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Shared mechanisms of astrocyte maturation in development and glioblastoma
$392,106Steven A Sloan · Emory University · R01 · FY2022 · NS
Therapeutic approaches to ER mutant breast cancer
$392,078Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Comprehensive genetic dissection of druggable KRAS targets
$392,078Steven D Leach · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Therapeutic approaches to ER mutant breast cancer
$392,078Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Comprehensive genetic dissection of druggable KRAS targets
$392,078Steven D Leach · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Project 3: Carbon and Electron FLASH radiotherapy for mitigation of normal lung injury in NSCLC
$392,074Amir Abdollahi · University Of Pennsylvania · P01 · FY2025 · CA
Effects of HSV-1 infection on neural progenitor cell biology in vitro and in vivo
$392,009Leonardo D'aiuto · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · NS
Rigidity and Shape Transitions in Living and Nonliving Matter
$392,000Jennifer Schwarz · Syracuse University · · FY2023 · MPS
TBEL Project 2
$391,973Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
$391,906David B. Solit · Columbia University Health Sciences · P01 · FY2020 · CA
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
$391,905David B. Solit · Columbia University Health Sciences · P01 · FY2021 · CA
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
$391,799Ankur Singh · Cornell University · R01 · FY2018 · AI
Role of Carbon Metabolism and Virulence of Shigella flexneri
$391,709Shelley M. Payne · University Of Texas At Austin · R37 · FY2025 · AI
Increasing organoid reproducibility and complexity for drug testing and disease modeling
$391,703Zev Jordan Gartner · University Of California, San Francisco · R33 · FY2025 · CA
Dissecting hybrid epithelial-mesenchymal states in head and neck cancer
$391,667Sidharth Venkata Puram · Washington University · R01 · FY2023 · DE
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
$391,638Deepak Ashok Lamba · University Of California, San Francisco · R01 · FY2022 · EY